Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study.

about

Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study.

Item

http://www.wikidata.org/entity/Q48279889

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Organ damage changes in patien ...... Hipertensión Arterial) study.

@en

Organ damage changes in patien ...... spironolactone: The DENERVHTA

@nl

type

Item

label

Organ damage changes in patien ...... Hipertensión Arterial) study.

@en

Organ damage changes in patien ...... spironolactone: The DENERVHTA

@nl

prefLabel

Organ damage changes in patien ...... Hipertensión Arterial) study.

@en

Organ damage changes in patien ...... spironolactone: The DENERVHTA

@nl

P1476

Organ damage changes in patien ...... Hipertensión Arterial) study.

@en

P2093

Albert Clarà

http://www.w3.org/2001/XMLSchema#string

Alejandro de la Sierra

http://www.w3.org/2001/XMLSchema#string

Julio Pascual

http://www.w3.org/2001/XMLSchema#string

Júlia Pareja

http://www.w3.org/2001/XMLSchema#string

Laia Sans

http://www.w3.org/2001/XMLSchema#string

Luis Molina

http://www.w3.org/2001/XMLSchema#string

Pedro Armario

http://www.w3.org/2001/XMLSchema#string

Susana Vázquez

http://www.w3.org/2001/XMLSchema#string

P2860

A controlled trial of renal denervation for resistant hypertension

Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.

A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients

Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness

Incidence and prognosis of resistant hypertension in hypertensive patients.

Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.

Effect of spironolactone in resistant arterial hypertension: a randomized, double-blind, placebo-controlled trial (ASPIRANT-EXT).

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

P304

69-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCH.13156

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anna Oliveras

P577

2018-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29316186

http://www.w3.org/2001/XMLSchema#string